The practical role of serum allergen-specific IgE as potential biomarker for predicting responder to allergen immunotherapy
Authors:
- Maria Angela ToscaMTMaria Angela Tosca
- Michela SilvestriMSMichela Silvestri
- 22 January 2014
- journal article
- Published by Taylor & Francis in Expert Review of Clinical Immunology
- Vol. 10 (3) , 321-324
Abstract
Allergic asthma and rhinitis are characterized by IgE-mediated inflammation consequent to the exposure to a specific allergen. Therefore, IgE production may be considered the hallmark of allergy. Actually, allergen immunotherapy (AIT) is the unique causal treatment for respiratory allergy. Indeed, successful AIT can induce a physiologic immune tolerance toward the causal allergen. There is evidence to show that AIT is safe and effective; its indication has been rigorously stated by robust position papers. AIT efficacy assessment is mainly based on symptom reduction and drug saving. AIT responder quote may range between 60 and 90% of AIT prescription. As AIT is expensive and long-lasting, the availability of a marker able to predict AIT responder is a crucial relevance. This issue has been the topic of several studies. Very recently, it has been preliminarly reported that a cut-off of serum specific IgE levels could define AIT-responder. However, further rigorous studies will confirm this view.Keywords
This publication has 12 references indexed in Scilit:
- Measurement of IgE to pollen allergen components is helpful in selecting patients for immunotherapyAnnals of Allergy, Asthma & Immunology, 2013
- What should drive the choice of allergen for immunotherapy in polysensitized patients?Annals of Allergy, Asthma & Immunology, 2012
- Analysis of allergen immunotherapy studies shows increased clinical efficacy in highly symptomatic patientsAllergy, 2011
- Immunological mechanisms of allergen-specific immunotherapyAllergy, 2011
- Increase of regulatory T cells and the ratio of specific IgE to total IgE are candidates for response monitoring or prognostic biomarkers in 2-year sublingual immunotherapy (SLIT) for Japanese cedar pollinosisClinical Immunology, 2011
- Comparison of Serum Specific IgE and Skin Prick Test in Polysensitized PatientsInternational Journal of Immunopathology and Pharmacology, 2010
- Immunoglobulin Production Pattern is Allergen-Specific in Polysensitized PatientsInternational Journal of Immunopathology and Pharmacology, 2009
- Evaluation of serum s-IgE/total IgE ratio in predicting clinical response to allergen-specific immunotherapyJournal of Allergy and Clinical Immunology, 2009
- Skin Test Results but not Serology Reflect Immediate Type Respiratory Sensitivity: A Study Performed with Recombinant Allergen MoleculesJournal of Investigative Dermatology, 2001
- Allergen immunotherapy: Therapeutic vaccines for allergic diseases A WHO position paperJournal of Allergy and Clinical Immunology, 1998